NCT01594242
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,608 public trials
494 recruiting studies
Multiple Myeloma trial results
NCT01246063
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT01383928
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCSF Medical Center Berkeley, California, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford University Stanford, California, United States
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma
NCT01556438
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan
NCT00807599
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering West Harrison Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02026505
- Conditions
- Blood Protein Disorders, Cardiotoxins, Cardiovascular Diseases, +16 more
- Locations
-
Not specified
NCT02497378
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hiroshima, Japan
- Hitachi, Japan
- Nagoya, Japan
- Shibuya City, Japan
NCT00520130
- Conditions
- Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01440582
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01481194
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Department of Hematology Vejle, Denmark